These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 11948373

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model.
    Hashiya N, Aoki M, Tachibana K, Taniyama Y, Yamasaki K, Hiraoka K, Makino H, Yasufumi K, Ogihara T, Morishita R.
    Biochem Biophys Res Commun; 2004 Apr 30; 317(2):508-14. PubMed ID: 15063786
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia.
    Ahn JD, Morishita R, Kaneda Y, Kim HS, Chang YC, Lee KU, Park JY, Lee HW, Kim YH, Lee IK.
    Gene Ther; 2002 Dec 30; 9(24):1682-92. PubMed ID: 12457282
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NFkappaB and E2F in a rabbit model.
    Miyake T, Aoki M, Morishita R.
    Cardiovasc Res; 2008 Sep 01; 79(4):706-14. PubMed ID: 18515844
    [Abstract] [Full Text] [Related]

  • 11. EGR-1 decoy ODNs inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of balloon-injured arteries in rat.
    Han W, Liu GN.
    Life Sci; 2010 Feb 13; 86(7-8):234-43. PubMed ID: 20025889
    [Abstract] [Full Text] [Related]

  • 12. Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis.
    Tomita N, Kim JY, Gibbons GH, Zhang L, Kaneda Y, Stahl RA, Ogborn M, Venderville B, Morishita R, Baran D, Dzau VJ.
    Int J Mol Med; 2004 May 13; 13(5):629-36. PubMed ID: 15067361
    [Abstract] [Full Text] [Related]

  • 13. In vivo transfection of a cis element 'decoy' against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model.
    Yokozeki H, Wu MH, Sumi K, Awad S, Satoh T, Katayama I, Takeda K, Akira S, Kaneda Y, Nishioka K.
    Gene Ther; 2004 Dec 13; 11(24):1753-62. PubMed ID: 15306842
    [Abstract] [Full Text] [Related]

  • 14. Transfection of the DNA for the receptor KDR/flk-1 attenuates neointimal proliferation and luminal narrowing in a coronary stent angioplasty model.
    Buchwald AB, Kunze C, Waltenberger J, Unterberg-Buchwald C.
    J Surg Res; 2006 Nov 13; 136(1):120-4. PubMed ID: 16979662
    [Abstract] [Full Text] [Related]

  • 15. Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits.
    Kalinowski M, Viehofer K, Hamann C, Barry JJ, Kleb B, Klose KJ, Wagner HJ, Alfke H.
    Cardiovasc Intervent Radiol; 2005 Nov 13; 28(3):331-7. PubMed ID: 15886949
    [Abstract] [Full Text] [Related]

  • 16. Suppression of proliferative cholangitis by E2F decoy oligodeoxynucleotide.
    Yoshida M, Yamamoto N, Nitta T, Uehara T, Terao R, Hatano E, Iimuro Y, Yamaoka Y.
    J Surg Res; 2002 Feb 13; 102(2):95-101. PubMed ID: 11796004
    [Abstract] [Full Text] [Related]

  • 17. Gene therapy for attenuating cardiac allograft arteriopathy using ex vivo E2F decoy transfection by HVJ-AVE-liposome method in mice and nonhuman primates.
    Kawauchi M, Suzuki J, Morishita R, Wada Y, Izawa A, Tomita N, Amano J, Kaneda Y, Ogihara T, Takamoto S, Isobe M.
    Circ Res; 2000 Nov 24; 87(11):1063-8. PubMed ID: 11090553
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.
    Morishita R, Gibbons GH, Horiuchi M, Ellison KE, Nakama M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ.
    Proc Natl Acad Sci U S A; 1995 Jun 20; 92(13):5855-9. PubMed ID: 7597041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.